Journal of Hematology & Oncology-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2151674, encodeId=c40221516e46a, content=请问收个案吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc925311076, createdName=14889669m60暂无昵称, createdTime=Mon Aug 07 20:23:36 CST 2023, time=2023-08-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2153449, encodeId=d1e3215344999, content=偏重的研究方向：肿瘤 经验分享：这个杂志太bug了，我们投稿两个半月，中间显示有5个reviewer accepted，最后居然说没有找到reviewer，就把我们拒了。简直太不负责任了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=Forever066, createdTime=Fri Aug 18 19:19:26 CST 2023, time=2023-08-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2099386, encodeId=3d62209938634, content=偏重的研究方向：肿瘤 经验分享：投过的大神们，Editor appointed 需要多久呢？感谢～～～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Nov 09 13:53:25 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067227, encodeId=ae76106e22758, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：实验楼不同方向课题组在一年内试投过5篇，2篇10天内拒稿，2篇送外审一个月后拒稿，1篇大修后接收。请3-4个审稿人，审稿人看的非常细，专业性很强，有创新性要求，article不容易中，基本要所有审稿人都给积极意见才能有机会修回。一般一审10天，送外审的再加3周，从投稿到返回外审意见1个半月。修回再投同样经历送外审差不多一个月返回意见。(状态会经历new submission，editor assigned，reviewer assigned，under review，reviews completed，editor assigned，revise，revise submission，editor assigned，reviewer assigned，under review，reviews completed，editor assigned，accept), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dac42363429, createdName=billljc, createdTime=Fri Nov 05 11:52:37 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130622, encodeId=b37c2130622b1, content=杂志对数据量和创新性要求还是比较高的，最近有幸中了一篇，编辑的效率还是非常高的，审稿人提的意见也很中肯很有帮助，整体上还是一次不错的投稿体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a0b5097949, createdName=145e9bd3m31暂无昵称, createdTime=Sat May 06 21:48:41 CST 2023, time=2023-05-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2134187, encodeId=5198213418e62, content=偏重的研究方向：肠癌 经验分享：投稿两周，终于有状态变化了，找到了一个reviewer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=ms1000001060102639, createdTime=Mon May 15 14:14:39 CST 2023, time=2023-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2126749, encodeId=90a72126e498b, content=投稿之后一直是Editor appointed 点进去是peer review请问这个状态会维持多久？看实验室其他人的两天就拒了，我的怎么编辑一直不处理, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9886482099, createdName=ms7000000166750616, createdTime=Tue Apr 18 14:20:59 CST 2023, time=2023-04-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2102008, encodeId=48142102008cc, content=投稿三周了，还是editor appointed，这算正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ae45165239, createdName=146c5a24m26(暂无昵称), createdTime=Tue Nov 22 16:15:17 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590985, encodeId=4eaf590985df, content=这个杂志reviewers assigned 要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qILWhXXjicV61sAexY6Hpic7WjVWiaY9Z8ia6SyQWBKjIhRKZsd8fK9PP9291FKd4dABfrQ/132, createdBy=09475256862, createdName=冰之凝朵, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190893, encodeId=f214119089312, content=这个期刊的系统换了，有小伙伴今年投稿了吗可否分享下投稿状态实时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Tue Feb 08 00:50:51 CST 2022, time=2022-02-08, status=1, ipAttribution=)]

2023-08-07 14889669m60暂无昵称来自四川省

请问收个案吗？

23 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2151674, encodeId=c40221516e46a, content=请问收个案吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc925311076, createdName=14889669m60暂无昵称, createdTime=Mon Aug 07 20:23:36 CST 2023, time=2023-08-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2153449, encodeId=d1e3215344999, content=偏重的研究方向：肿瘤 经验分享：这个杂志太bug了，我们投稿两个半月，中间显示有5个reviewer accepted，最后居然说没有找到reviewer，就把我们拒了。简直太不负责任了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=Forever066, createdTime=Fri Aug 18 19:19:26 CST 2023, time=2023-08-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2099386, encodeId=3d62209938634, content=偏重的研究方向：肿瘤 经验分享：投过的大神们，Editor appointed 需要多久呢？感谢～～～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Nov 09 13:53:25 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067227, encodeId=ae76106e22758, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：实验楼不同方向课题组在一年内试投过5篇，2篇10天内拒稿，2篇送外审一个月后拒稿，1篇大修后接收。请3-4个审稿人，审稿人看的非常细，专业性很强，有创新性要求，article不容易中，基本要所有审稿人都给积极意见才能有机会修回。一般一审10天，送外审的再加3周，从投稿到返回外审意见1个半月。修回再投同样经历送外审差不多一个月返回意见。(状态会经历new submission，editor assigned，reviewer assigned，under review，reviews completed，editor assigned，revise，revise submission，editor assigned，reviewer assigned，under review，reviews completed，editor assigned，accept), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dac42363429, createdName=billljc, createdTime=Fri Nov 05 11:52:37 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130622, encodeId=b37c2130622b1, content=杂志对数据量和创新性要求还是比较高的，最近有幸中了一篇，编辑的效率还是非常高的，审稿人提的意见也很中肯很有帮助，整体上还是一次不错的投稿体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a0b5097949, createdName=145e9bd3m31暂无昵称, createdTime=Sat May 06 21:48:41 CST 2023, time=2023-05-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2134187, encodeId=5198213418e62, content=偏重的研究方向：肠癌 经验分享：投稿两周，终于有状态变化了，找到了一个reviewer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=ms1000001060102639, createdTime=Mon May 15 14:14:39 CST 2023, time=2023-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2126749, encodeId=90a72126e498b, content=投稿之后一直是Editor appointed 点进去是peer review请问这个状态会维持多久？看实验室其他人的两天就拒了，我的怎么编辑一直不处理, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9886482099, createdName=ms7000000166750616, createdTime=Tue Apr 18 14:20:59 CST 2023, time=2023-04-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2102008, encodeId=48142102008cc, content=投稿三周了，还是editor appointed，这算正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ae45165239, createdName=146c5a24m26(暂无昵称), createdTime=Tue Nov 22 16:15:17 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590985, encodeId=4eaf590985df, content=这个杂志reviewers assigned 要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qILWhXXjicV61sAexY6Hpic7WjVWiaY9Z8ia6SyQWBKjIhRKZsd8fK9PP9291FKd4dABfrQ/132, createdBy=09475256862, createdName=冰之凝朵, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190893, encodeId=f214119089312, content=这个期刊的系统换了，有小伙伴今年投稿了吗可否分享下投稿状态实时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Tue Feb 08 00:50:51 CST 2022, time=2022-02-08, status=1, ipAttribution=)]

2023-08-18 Forever066 来自广东省

偏重的研究方向：肿瘤
经验分享：这个杂志太bug了，我们投稿两个半月，中间显示有5个reviewer accepted，最后居然说没有找到reviewer，就把我们拒了。简直太不负责任了！

12 0

[GetPortalCommentsPageByObjectIdResponse(id=2151674, encodeId=c40221516e46a, content=请问收个案吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc925311076, createdName=14889669m60暂无昵称, createdTime=Mon Aug 07 20:23:36 CST 2023, time=2023-08-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2153449, encodeId=d1e3215344999, content=偏重的研究方向：肿瘤 经验分享：这个杂志太bug了，我们投稿两个半月，中间显示有5个reviewer accepted，最后居然说没有找到reviewer，就把我们拒了。简直太不负责任了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=Forever066, createdTime=Fri Aug 18 19:19:26 CST 2023, time=2023-08-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2099386, encodeId=3d62209938634, content=偏重的研究方向：肿瘤 经验分享：投过的大神们，Editor appointed 需要多久呢？感谢～～～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Nov 09 13:53:25 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067227, encodeId=ae76106e22758, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：实验楼不同方向课题组在一年内试投过5篇，2篇10天内拒稿，2篇送外审一个月后拒稿，1篇大修后接收。请3-4个审稿人，审稿人看的非常细，专业性很强，有创新性要求，article不容易中，基本要所有审稿人都给积极意见才能有机会修回。一般一审10天，送外审的再加3周，从投稿到返回外审意见1个半月。修回再投同样经历送外审差不多一个月返回意见。(状态会经历new submission，editor assigned，reviewer assigned，under review，reviews completed，editor assigned，revise，revise submission，editor assigned，reviewer assigned，under review，reviews completed，editor assigned，accept), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dac42363429, createdName=billljc, createdTime=Fri Nov 05 11:52:37 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130622, encodeId=b37c2130622b1, content=杂志对数据量和创新性要求还是比较高的，最近有幸中了一篇，编辑的效率还是非常高的，审稿人提的意见也很中肯很有帮助，整体上还是一次不错的投稿体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a0b5097949, createdName=145e9bd3m31暂无昵称, createdTime=Sat May 06 21:48:41 CST 2023, time=2023-05-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2134187, encodeId=5198213418e62, content=偏重的研究方向：肠癌 经验分享：投稿两周，终于有状态变化了，找到了一个reviewer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=ms1000001060102639, createdTime=Mon May 15 14:14:39 CST 2023, time=2023-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2126749, encodeId=90a72126e498b, content=投稿之后一直是Editor appointed 点进去是peer review请问这个状态会维持多久？看实验室其他人的两天就拒了，我的怎么编辑一直不处理, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9886482099, createdName=ms7000000166750616, createdTime=Tue Apr 18 14:20:59 CST 2023, time=2023-04-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2102008, encodeId=48142102008cc, content=投稿三周了，还是editor appointed，这算正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ae45165239, createdName=146c5a24m26(暂无昵称), createdTime=Tue Nov 22 16:15:17 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590985, encodeId=4eaf590985df, content=这个杂志reviewers assigned 要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qILWhXXjicV61sAexY6Hpic7WjVWiaY9Z8ia6SyQWBKjIhRKZsd8fK9PP9291FKd4dABfrQ/132, createdBy=09475256862, createdName=冰之凝朵, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190893, encodeId=f214119089312, content=这个期刊的系统换了，有小伙伴今年投稿了吗可否分享下投稿状态实时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Tue Feb 08 00:50:51 CST 2022, time=2022-02-08, status=1, ipAttribution=)]

2022-11-09 a201061519

偏重的研究方向：肿瘤
经验分享：投过的大神们，Editor appointed 需要多久呢？感谢～～～

74 7

展开7条回复

[GetPortalCommentsPageByObjectIdResponse(id=2151674, encodeId=c40221516e46a, content=请问收个案吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc925311076, createdName=14889669m60暂无昵称, createdTime=Mon Aug 07 20:23:36 CST 2023, time=2023-08-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2153449, encodeId=d1e3215344999, content=偏重的研究方向：肿瘤 经验分享：这个杂志太bug了，我们投稿两个半月，中间显示有5个reviewer accepted，最后居然说没有找到reviewer，就把我们拒了。简直太不负责任了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=Forever066, createdTime=Fri Aug 18 19:19:26 CST 2023, time=2023-08-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2099386, encodeId=3d62209938634, content=偏重的研究方向：肿瘤 经验分享：投过的大神们，Editor appointed 需要多久呢？感谢～～～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Nov 09 13:53:25 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067227, encodeId=ae76106e22758, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：实验楼不同方向课题组在一年内试投过5篇，2篇10天内拒稿，2篇送外审一个月后拒稿，1篇大修后接收。请3-4个审稿人，审稿人看的非常细，专业性很强，有创新性要求，article不容易中，基本要所有审稿人都给积极意见才能有机会修回。一般一审10天，送外审的再加3周，从投稿到返回外审意见1个半月。修回再投同样经历送外审差不多一个月返回意见。(状态会经历new submission，editor assigned，reviewer assigned，under review，reviews completed，editor assigned，revise，revise submission，editor assigned，reviewer assigned，under review，reviews completed，editor assigned，accept), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dac42363429, createdName=billljc, createdTime=Fri Nov 05 11:52:37 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130622, encodeId=b37c2130622b1, content=杂志对数据量和创新性要求还是比较高的，最近有幸中了一篇，编辑的效率还是非常高的，审稿人提的意见也很中肯很有帮助，整体上还是一次不错的投稿体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a0b5097949, createdName=145e9bd3m31暂无昵称, createdTime=Sat May 06 21:48:41 CST 2023, time=2023-05-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2134187, encodeId=5198213418e62, content=偏重的研究方向：肠癌 经验分享：投稿两周，终于有状态变化了，找到了一个reviewer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=ms1000001060102639, createdTime=Mon May 15 14:14:39 CST 2023, time=2023-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2126749, encodeId=90a72126e498b, content=投稿之后一直是Editor appointed 点进去是peer review请问这个状态会维持多久？看实验室其他人的两天就拒了，我的怎么编辑一直不处理, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9886482099, createdName=ms7000000166750616, createdTime=Tue Apr 18 14:20:59 CST 2023, time=2023-04-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2102008, encodeId=48142102008cc, content=投稿三周了，还是editor appointed，这算正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ae45165239, createdName=146c5a24m26(暂无昵称), createdTime=Tue Nov 22 16:15:17 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590985, encodeId=4eaf590985df, content=这个杂志reviewers assigned 要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qILWhXXjicV61sAexY6Hpic7WjVWiaY9Z8ia6SyQWBKjIhRKZsd8fK9PP9291FKd4dABfrQ/132, createdBy=09475256862, createdName=冰之凝朵, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190893, encodeId=f214119089312, content=这个期刊的系统换了，有小伙伴今年投稿了吗可否分享下投稿状态实时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Tue Feb 08 00:50:51 CST 2022, time=2022-02-08, status=1, ipAttribution=)]

2021-11-05 billljc

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：肿瘤
经验分享：实验楼不同方向课题组在一年内试投过5篇，2篇10天内拒稿，2篇送外审一个月后拒稿，1篇大修后接收。请3-4个审稿人，审稿人看的非常细，专业性很强，有创新性要求，article不容易中，基本要所有审稿人都给积极意见才能有机会修回。一般一审10天，送外审的再加3周，从投稿到返回外审意见1个半月。修回再投同样经历送外审差不多一个月返回意见。(状态会经历new submission，editor assigned，reviewer assigned，under review，reviews completed，editor assigned，revise，revise submission，editor assigned，reviewer assigned，under review，reviews completed，editor assigned，accept)

92 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2151674, encodeId=c40221516e46a, content=请问收个案吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc925311076, createdName=14889669m60暂无昵称, createdTime=Mon Aug 07 20:23:36 CST 2023, time=2023-08-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2153449, encodeId=d1e3215344999, content=偏重的研究方向：肿瘤 经验分享：这个杂志太bug了，我们投稿两个半月，中间显示有5个reviewer accepted，最后居然说没有找到reviewer，就把我们拒了。简直太不负责任了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=Forever066, createdTime=Fri Aug 18 19:19:26 CST 2023, time=2023-08-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2099386, encodeId=3d62209938634, content=偏重的研究方向：肿瘤 经验分享：投过的大神们，Editor appointed 需要多久呢？感谢～～～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Nov 09 13:53:25 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067227, encodeId=ae76106e22758, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：实验楼不同方向课题组在一年内试投过5篇，2篇10天内拒稿，2篇送外审一个月后拒稿，1篇大修后接收。请3-4个审稿人，审稿人看的非常细，专业性很强，有创新性要求，article不容易中，基本要所有审稿人都给积极意见才能有机会修回。一般一审10天，送外审的再加3周，从投稿到返回外审意见1个半月。修回再投同样经历送外审差不多一个月返回意见。(状态会经历new submission，editor assigned，reviewer assigned，under review，reviews completed，editor assigned，revise，revise submission，editor assigned，reviewer assigned，under review，reviews completed，editor assigned，accept), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dac42363429, createdName=billljc, createdTime=Fri Nov 05 11:52:37 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130622, encodeId=b37c2130622b1, content=杂志对数据量和创新性要求还是比较高的，最近有幸中了一篇，编辑的效率还是非常高的，审稿人提的意见也很中肯很有帮助，整体上还是一次不错的投稿体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a0b5097949, createdName=145e9bd3m31暂无昵称, createdTime=Sat May 06 21:48:41 CST 2023, time=2023-05-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2134187, encodeId=5198213418e62, content=偏重的研究方向：肠癌 经验分享：投稿两周，终于有状态变化了，找到了一个reviewer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=ms1000001060102639, createdTime=Mon May 15 14:14:39 CST 2023, time=2023-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2126749, encodeId=90a72126e498b, content=投稿之后一直是Editor appointed 点进去是peer review请问这个状态会维持多久？看实验室其他人的两天就拒了，我的怎么编辑一直不处理, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9886482099, createdName=ms7000000166750616, createdTime=Tue Apr 18 14:20:59 CST 2023, time=2023-04-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2102008, encodeId=48142102008cc, content=投稿三周了，还是editor appointed，这算正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ae45165239, createdName=146c5a24m26(暂无昵称), createdTime=Tue Nov 22 16:15:17 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590985, encodeId=4eaf590985df, content=这个杂志reviewers assigned 要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qILWhXXjicV61sAexY6Hpic7WjVWiaY9Z8ia6SyQWBKjIhRKZsd8fK9PP9291FKd4dABfrQ/132, createdBy=09475256862, createdName=冰之凝朵, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190893, encodeId=f214119089312, content=这个期刊的系统换了，有小伙伴今年投稿了吗可否分享下投稿状态实时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Tue Feb 08 00:50:51 CST 2022, time=2022-02-08, status=1, ipAttribution=)]

2023-05-06 145e9bd3m31暂无昵称来自广东省

杂志对数据量和创新性要求还是比较高的，最近有幸中了一篇，编辑的效率还是非常高的，审稿人提的意见也很中肯很有帮助，整体上还是一次不错的投稿体验

48 4

展开4条回复

[GetPortalCommentsPageByObjectIdResponse(id=2151674, encodeId=c40221516e46a, content=请问收个案吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc925311076, createdName=14889669m60暂无昵称, createdTime=Mon Aug 07 20:23:36 CST 2023, time=2023-08-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2153449, encodeId=d1e3215344999, content=偏重的研究方向：肿瘤 经验分享：这个杂志太bug了，我们投稿两个半月，中间显示有5个reviewer accepted，最后居然说没有找到reviewer，就把我们拒了。简直太不负责任了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=Forever066, createdTime=Fri Aug 18 19:19:26 CST 2023, time=2023-08-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2099386, encodeId=3d62209938634, content=偏重的研究方向：肿瘤 经验分享：投过的大神们，Editor appointed 需要多久呢？感谢～～～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Nov 09 13:53:25 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067227, encodeId=ae76106e22758, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：实验楼不同方向课题组在一年内试投过5篇，2篇10天内拒稿，2篇送外审一个月后拒稿，1篇大修后接收。请3-4个审稿人，审稿人看的非常细，专业性很强，有创新性要求，article不容易中，基本要所有审稿人都给积极意见才能有机会修回。一般一审10天，送外审的再加3周，从投稿到返回外审意见1个半月。修回再投同样经历送外审差不多一个月返回意见。(状态会经历new submission，editor assigned，reviewer assigned，under review，reviews completed，editor assigned，revise，revise submission，editor assigned，reviewer assigned，under review，reviews completed，editor assigned，accept), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dac42363429, createdName=billljc, createdTime=Fri Nov 05 11:52:37 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130622, encodeId=b37c2130622b1, content=杂志对数据量和创新性要求还是比较高的，最近有幸中了一篇，编辑的效率还是非常高的，审稿人提的意见也很中肯很有帮助，整体上还是一次不错的投稿体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a0b5097949, createdName=145e9bd3m31暂无昵称, createdTime=Sat May 06 21:48:41 CST 2023, time=2023-05-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2134187, encodeId=5198213418e62, content=偏重的研究方向：肠癌 经验分享：投稿两周，终于有状态变化了，找到了一个reviewer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=ms1000001060102639, createdTime=Mon May 15 14:14:39 CST 2023, time=2023-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2126749, encodeId=90a72126e498b, content=投稿之后一直是Editor appointed 点进去是peer review请问这个状态会维持多久？看实验室其他人的两天就拒了，我的怎么编辑一直不处理, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9886482099, createdName=ms7000000166750616, createdTime=Tue Apr 18 14:20:59 CST 2023, time=2023-04-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2102008, encodeId=48142102008cc, content=投稿三周了，还是editor appointed，这算正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ae45165239, createdName=146c5a24m26(暂无昵称), createdTime=Tue Nov 22 16:15:17 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590985, encodeId=4eaf590985df, content=这个杂志reviewers assigned 要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qILWhXXjicV61sAexY6Hpic7WjVWiaY9Z8ia6SyQWBKjIhRKZsd8fK9PP9291FKd4dABfrQ/132, createdBy=09475256862, createdName=冰之凝朵, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190893, encodeId=f214119089312, content=这个期刊的系统换了，有小伙伴今年投稿了吗可否分享下投稿状态实时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Tue Feb 08 00:50:51 CST 2022, time=2022-02-08, status=1, ipAttribution=)]

2023-05-15 ms1000001060102639 来自广东省

偏重的研究方向：肠癌
经验分享：投稿两周，终于有状态变化了，找到了一个reviewer

49 0

[GetPortalCommentsPageByObjectIdResponse(id=2151674, encodeId=c40221516e46a, content=请问收个案吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc925311076, createdName=14889669m60暂无昵称, createdTime=Mon Aug 07 20:23:36 CST 2023, time=2023-08-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2153449, encodeId=d1e3215344999, content=偏重的研究方向：肿瘤 经验分享：这个杂志太bug了，我们投稿两个半月，中间显示有5个reviewer accepted，最后居然说没有找到reviewer，就把我们拒了。简直太不负责任了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=Forever066, createdTime=Fri Aug 18 19:19:26 CST 2023, time=2023-08-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2099386, encodeId=3d62209938634, content=偏重的研究方向：肿瘤 经验分享：投过的大神们，Editor appointed 需要多久呢？感谢～～～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Nov 09 13:53:25 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067227, encodeId=ae76106e22758, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：实验楼不同方向课题组在一年内试投过5篇，2篇10天内拒稿，2篇送外审一个月后拒稿，1篇大修后接收。请3-4个审稿人，审稿人看的非常细，专业性很强，有创新性要求，article不容易中，基本要所有审稿人都给积极意见才能有机会修回。一般一审10天，送外审的再加3周，从投稿到返回外审意见1个半月。修回再投同样经历送外审差不多一个月返回意见。(状态会经历new submission，editor assigned，reviewer assigned，under review，reviews completed，editor assigned，revise，revise submission，editor assigned，reviewer assigned，under review，reviews completed，editor assigned，accept), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dac42363429, createdName=billljc, createdTime=Fri Nov 05 11:52:37 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130622, encodeId=b37c2130622b1, content=杂志对数据量和创新性要求还是比较高的，最近有幸中了一篇，编辑的效率还是非常高的，审稿人提的意见也很中肯很有帮助，整体上还是一次不错的投稿体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a0b5097949, createdName=145e9bd3m31暂无昵称, createdTime=Sat May 06 21:48:41 CST 2023, time=2023-05-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2134187, encodeId=5198213418e62, content=偏重的研究方向：肠癌 经验分享：投稿两周，终于有状态变化了，找到了一个reviewer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=ms1000001060102639, createdTime=Mon May 15 14:14:39 CST 2023, time=2023-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2126749, encodeId=90a72126e498b, content=投稿之后一直是Editor appointed 点进去是peer review请问这个状态会维持多久？看实验室其他人的两天就拒了，我的怎么编辑一直不处理, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9886482099, createdName=ms7000000166750616, createdTime=Tue Apr 18 14:20:59 CST 2023, time=2023-04-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2102008, encodeId=48142102008cc, content=投稿三周了，还是editor appointed，这算正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ae45165239, createdName=146c5a24m26(暂无昵称), createdTime=Tue Nov 22 16:15:17 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590985, encodeId=4eaf590985df, content=这个杂志reviewers assigned 要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qILWhXXjicV61sAexY6Hpic7WjVWiaY9Z8ia6SyQWBKjIhRKZsd8fK9PP9291FKd4dABfrQ/132, createdBy=09475256862, createdName=冰之凝朵, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190893, encodeId=f214119089312, content=这个期刊的系统换了，有小伙伴今年投稿了吗可否分享下投稿状态实时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Tue Feb 08 00:50:51 CST 2022, time=2022-02-08, status=1, ipAttribution=)]

2023-04-18 ms7000000166750616 来自山东省

投稿之后一直是Editor appointed 点进去是peer review请问这个状态会维持多久？看实验室其他人的两天就拒了，我的怎么编辑一直不处理

52 6

展开6条回复

[GetPortalCommentsPageByObjectIdResponse(id=2151674, encodeId=c40221516e46a, content=请问收个案吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc925311076, createdName=14889669m60暂无昵称, createdTime=Mon Aug 07 20:23:36 CST 2023, time=2023-08-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2153449, encodeId=d1e3215344999, content=偏重的研究方向：肿瘤 经验分享：这个杂志太bug了，我们投稿两个半月，中间显示有5个reviewer accepted，最后居然说没有找到reviewer，就把我们拒了。简直太不负责任了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=Forever066, createdTime=Fri Aug 18 19:19:26 CST 2023, time=2023-08-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2099386, encodeId=3d62209938634, content=偏重的研究方向：肿瘤 经验分享：投过的大神们，Editor appointed 需要多久呢？感谢～～～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Nov 09 13:53:25 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067227, encodeId=ae76106e22758, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：实验楼不同方向课题组在一年内试投过5篇，2篇10天内拒稿，2篇送外审一个月后拒稿，1篇大修后接收。请3-4个审稿人，审稿人看的非常细，专业性很强，有创新性要求，article不容易中，基本要所有审稿人都给积极意见才能有机会修回。一般一审10天，送外审的再加3周，从投稿到返回外审意见1个半月。修回再投同样经历送外审差不多一个月返回意见。(状态会经历new submission，editor assigned，reviewer assigned，under review，reviews completed，editor assigned，revise，revise submission，editor assigned，reviewer assigned，under review，reviews completed，editor assigned，accept), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dac42363429, createdName=billljc, createdTime=Fri Nov 05 11:52:37 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130622, encodeId=b37c2130622b1, content=杂志对数据量和创新性要求还是比较高的，最近有幸中了一篇，编辑的效率还是非常高的，审稿人提的意见也很中肯很有帮助，整体上还是一次不错的投稿体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a0b5097949, createdName=145e9bd3m31暂无昵称, createdTime=Sat May 06 21:48:41 CST 2023, time=2023-05-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2134187, encodeId=5198213418e62, content=偏重的研究方向：肠癌 经验分享：投稿两周，终于有状态变化了，找到了一个reviewer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=ms1000001060102639, createdTime=Mon May 15 14:14:39 CST 2023, time=2023-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2126749, encodeId=90a72126e498b, content=投稿之后一直是Editor appointed 点进去是peer review请问这个状态会维持多久？看实验室其他人的两天就拒了，我的怎么编辑一直不处理, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9886482099, createdName=ms7000000166750616, createdTime=Tue Apr 18 14:20:59 CST 2023, time=2023-04-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2102008, encodeId=48142102008cc, content=投稿三周了，还是editor appointed，这算正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ae45165239, createdName=146c5a24m26(暂无昵称), createdTime=Tue Nov 22 16:15:17 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590985, encodeId=4eaf590985df, content=这个杂志reviewers assigned 要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qILWhXXjicV61sAexY6Hpic7WjVWiaY9Z8ia6SyQWBKjIhRKZsd8fK9PP9291FKd4dABfrQ/132, createdBy=09475256862, createdName=冰之凝朵, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190893, encodeId=f214119089312, content=这个期刊的系统换了，有小伙伴今年投稿了吗可否分享下投稿状态实时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Tue Feb 08 00:50:51 CST 2022, time=2022-02-08, status=1, ipAttribution=)]

2022-11-22 146c5a24m26(暂无昵称)

投稿三周了，还是editor appointed，这算正常的吗？

69 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=2151674, encodeId=c40221516e46a, content=请问收个案吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc925311076, createdName=14889669m60暂无昵称, createdTime=Mon Aug 07 20:23:36 CST 2023, time=2023-08-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2153449, encodeId=d1e3215344999, content=偏重的研究方向：肿瘤 经验分享：这个杂志太bug了，我们投稿两个半月，中间显示有5个reviewer accepted，最后居然说没有找到reviewer，就把我们拒了。简直太不负责任了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=Forever066, createdTime=Fri Aug 18 19:19:26 CST 2023, time=2023-08-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2099386, encodeId=3d62209938634, content=偏重的研究方向：肿瘤 经验分享：投过的大神们，Editor appointed 需要多久呢？感谢～～～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Nov 09 13:53:25 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067227, encodeId=ae76106e22758, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：实验楼不同方向课题组在一年内试投过5篇，2篇10天内拒稿，2篇送外审一个月后拒稿，1篇大修后接收。请3-4个审稿人，审稿人看的非常细，专业性很强，有创新性要求，article不容易中，基本要所有审稿人都给积极意见才能有机会修回。一般一审10天，送外审的再加3周，从投稿到返回外审意见1个半月。修回再投同样经历送外审差不多一个月返回意见。(状态会经历new submission，editor assigned，reviewer assigned，under review，reviews completed，editor assigned，revise，revise submission，editor assigned，reviewer assigned，under review，reviews completed，editor assigned，accept), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dac42363429, createdName=billljc, createdTime=Fri Nov 05 11:52:37 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130622, encodeId=b37c2130622b1, content=杂志对数据量和创新性要求还是比较高的，最近有幸中了一篇，编辑的效率还是非常高的，审稿人提的意见也很中肯很有帮助，整体上还是一次不错的投稿体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a0b5097949, createdName=145e9bd3m31暂无昵称, createdTime=Sat May 06 21:48:41 CST 2023, time=2023-05-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2134187, encodeId=5198213418e62, content=偏重的研究方向：肠癌 经验分享：投稿两周，终于有状态变化了，找到了一个reviewer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=ms1000001060102639, createdTime=Mon May 15 14:14:39 CST 2023, time=2023-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2126749, encodeId=90a72126e498b, content=投稿之后一直是Editor appointed 点进去是peer review请问这个状态会维持多久？看实验室其他人的两天就拒了，我的怎么编辑一直不处理, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9886482099, createdName=ms7000000166750616, createdTime=Tue Apr 18 14:20:59 CST 2023, time=2023-04-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2102008, encodeId=48142102008cc, content=投稿三周了，还是editor appointed，这算正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ae45165239, createdName=146c5a24m26(暂无昵称), createdTime=Tue Nov 22 16:15:17 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590985, encodeId=4eaf590985df, content=这个杂志reviewers assigned 要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qILWhXXjicV61sAexY6Hpic7WjVWiaY9Z8ia6SyQWBKjIhRKZsd8fK9PP9291FKd4dABfrQ/132, createdBy=09475256862, createdName=冰之凝朵, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190893, encodeId=f214119089312, content=这个期刊的系统换了，有小伙伴今年投稿了吗可否分享下投稿状态实时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Tue Feb 08 00:50:51 CST 2022, time=2022-02-08, status=1, ipAttribution=)]

2020-05-16 冰之凝朵

这个杂志reviewers assigned 要多久

187 11

展开11条回复

[GetPortalCommentsPageByObjectIdResponse(id=2151674, encodeId=c40221516e46a, content=请问收个案吗？ , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=23, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cc925311076, createdName=14889669m60暂无昵称, createdTime=Mon Aug 07 20:23:36 CST 2023, time=2023-08-07, status=1, ipAttribution=四川省), GetPortalCommentsPageByObjectIdResponse(id=2153449, encodeId=d1e3215344999, content=偏重的研究方向：肿瘤 经验分享：这个杂志太bug了，我们投稿两个半月，中间显示有5个reviewer accepted，最后居然说没有找到reviewer，就把我们拒了。简直太不负责任了！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=12, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=Forever066, createdTime=Fri Aug 18 19:19:26 CST 2023, time=2023-08-18, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2099386, encodeId=3d62209938634, content=偏重的研究方向：肿瘤 经验分享：投过的大神们，Editor appointed 需要多久呢？感谢～～～, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=74, replyNumber=7, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20221030/c5a5f92eeaa6438f9470120d9a013f6f/3a668fe12116417ba59aeafa300cd23b.jpg, createdBy=5a711629755, createdName=a201061519, createdTime=Wed Nov 09 13:53:25 CST 2022, time=2022-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1067227, encodeId=ae76106e22758, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：肿瘤 经验分享：实验楼不同方向课题组在一年内试投过5篇，2篇10天内拒稿，2篇送外审一个月后拒稿，1篇大修后接收。请3-4个审稿人，审稿人看的非常细，专业性很强，有创新性要求，article不容易中，基本要所有审稿人都给积极意见才能有机会修回。一般一审10天，送外审的再加3周，从投稿到返回外审意见1个半月。修回再投同样经历送外审差不多一个月返回意见。(状态会经历new submission，editor assigned，reviewer assigned，under review，reviews completed，editor assigned，revise，revise submission，editor assigned，reviewer assigned，under review，reviews completed，editor assigned，accept), beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=92, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=dac42363429, createdName=billljc, createdTime=Fri Nov 05 11:52:37 CST 2021, time=2021-11-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2130622, encodeId=b37c2130622b1, content=杂志对数据量和创新性要求还是比较高的，最近有幸中了一篇，编辑的效率还是非常高的，审稿人提的意见也很中肯很有帮助，整体上还是一次不错的投稿体验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=48, replyNumber=4, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4a0b5097949, createdName=145e9bd3m31暂无昵称, createdTime=Sat May 06 21:48:41 CST 2023, time=2023-05-06, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2134187, encodeId=5198213418e62, content=偏重的研究方向：肠癌 经验分享：投稿两周，终于有状态变化了，找到了一个reviewer, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=55d38610766, createdName=ms1000001060102639, createdTime=Mon May 15 14:14:39 CST 2023, time=2023-05-15, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2126749, encodeId=90a72126e498b, content=投稿之后一直是Editor appointed 点进去是peer review请问这个状态会维持多久？看实验室其他人的两天就拒了，我的怎么编辑一直不处理, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=52, replyNumber=6, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9886482099, createdName=ms7000000166750616, createdTime=Tue Apr 18 14:20:59 CST 2023, time=2023-04-18, status=1, ipAttribution=山东省), GetPortalCommentsPageByObjectIdResponse(id=2102008, encodeId=48142102008cc, content=投稿三周了，还是editor appointed，这算正常的吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=69, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2ae45165239, createdName=146c5a24m26(暂无昵称), createdTime=Tue Nov 22 16:15:17 CST 2022, time=2022-11-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=590985, encodeId=4eaf590985df, content=这个杂志reviewers assigned 要多久, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=187, replyNumber=11, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/DYAIOgq83epppOIrNy2qILWhXXjicV61sAexY6Hpic7WjVWiaY9Z8ia6SyQWBKjIhRKZsd8fK9PP9291FKd4dABfrQ/132, createdBy=09475256862, createdName=冰之凝朵, createdTime=Sat May 16 00:00:00 CST 2020, time=2020-05-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1190893, encodeId=f214119089312, content=这个期刊的系统换了，有小伙伴今年投稿了吗可否分享下投稿状态实时更新, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=116, replyNumber=8, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7ec85701429, createdName=灵动梦幻, createdTime=Tue Feb 08 00:50:51 CST 2022, time=2022-02-08, status=1, ipAttribution=)]

2022-02-08 灵动梦幻

这个期刊的系统换了，有小伙伴今年投稿了吗可否分享下投稿状态实时更新

116 8

展开8条回复

内科

外科

专科科室

热点

按科室浏览

科研工具

写作工具

其他工具

平台业务解决方案

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务